Alexandre Sepriano

📣 Coming soon… ARP Rheumatology x @SPReumatologia are launching a new initiative to train the next generation of scientific reviewers If you're an SPR member interested in peer review & publishing — stay tuned. 🔜 Announcement very soon #Rheumatology #PeerReview #SPR #ARP

We are delighted to welcome Prof. @AlexSepriano as Methodological & Statistical Reviewer A former Editor-in-Chief (2021–2025 and expert in epidemiology, biostatistics, and imaging outcomes, he strengthens our commitment to research excellence Welcome back! 👏📊

🧬 Rheumatoid nodules can be refractory—or even worsen—despite good joint control in RA. 📉 New case evidence shows cutaneous & pulmonary nodule regression with upadacitinib ➡️ Suggesting JAK inhibition effects beyond synovitis 🔗arprheumatology.com/section.php?id…

🌟 Thank you to the Top Reviewers of ARP Rheumatology 2025 Your expertise and dedication to rigorous peer review help advance excellence in rheumatology research 🔬📘 Thank you for your invaluable contribution to advancing excellence in rheumatology research 💙

Season’s Greetings from ARP Rheumatology ✨ Grateful to our amazing community for another year of collaboration and science. Wishing you happy holidays and a healthy New Year! 📷 🌟

Last month, Sophia Rein was awarded a grant during the 2025 ADIA Lab symposium. ‘Causal AI for the Generation of Real-World Evidence from Healthcare Data’ will support software development for Causal AI (combining the g-formula with deep learning). Congrats, Sophia!

Difficult-to-manage #PsoriaticArthritis Include drivers such as ▶️Inflammation ▶️Comorbidities ▶️Psychosocial or other factors Treatment-refractory PsA ▶️Persistent disease activity ▶️Objective evidence of active inflammation 👉🏽ard.eular.org/article/S0003-… via @eular_ARD @eular_org

🩺 Clinical Case Challenge A 62-year-old woman presents with: 🫗 Bilateral parotid swelling 👁️ Dry eyes/mouth 🧠 Fatigue & weight loss 🧪 Labs: cytopenia, ↓complement, ↑ACE, ↑β₂-microglobulin 📸 Imaging: enlarged parotids + lymphadenopathy ⭐️ What’s the most likely diagnosis?

🚨 New editorial in ARP Rheumatology: 5 years at a glance 📖 309 articles 🌍 ~50% international ⏱️ 36% faster publication 🔗 20 Reuma.pt studies 🌐 Expanded digital & SM presence Read 👉 arprheumatology.com/section.php?id…

📰 Don’t miss this month’s Editor’s Choice selected by Prof @TaniaLSantiago ✨ 📌 PORTRESS: first nationwide registry for Sjögren’s in Portugal 🇵🇹 📌 Cervical CPPD 📌 ASAS definition of D2M & TR axSpA: first real-world insights 🔗 Read FREE: arprheumatology.com

📢Online First Pemphigus foliaceus case with atypical hypocomplementemic urticarial vasculitis Findings: hypocomplementemia + thrombocytopenia + hepatomegaly → B-cell lymphoproliferative disorder ⚠️ Vasculitic lesions may signal malignancy 🔗 arprheumatology.com/article_abstra…

✨The 2024 IF for ARP Rheumatology is 1.4! 📈 Our first total IF under the new name keeps the growth from 1.375 in 2022, securing a solid Q3 position. 🙏 Thank you to our authors, reviewers, Associate Editors & community for making this possible — and here’s to more growth ahead!

It’s World AS Day! How are you spreading awareness about axial spondyloarthritis today? Share your activities in the comments. Thank you to everyone raising awareness and driving change today! #WorldASDay2025 #LaceUpForAxSpA #EverydayChallenges

New from the Slide Library: ASAS publication from @AlexSepriano et al Higher ASDAS was longitudinally associated with higher spinal radiographic progression in patients with r-axSpA independently of treatment with TNFi. 👉 pubmed.ncbi.nlm.nih.gov/33118014/

📣 MORE NEWS FROM ASAS Congratulations to Prof. Raj Sengupta on his election to the ASAS Executive Committee! We are also pleased to announce Prof. Pedro Machado’s new role as Executive Secretary of the ASAS Executive Committee. #asas2025 #asa30yrs

Mark your calendars for an essential session at the ASAS Core Course! Dr. Baraliakos will present his viewpoint on 'Rethinking Structural Progression in axSpA: A Balanced Approach.' #SpA #Rheumatology #ASASCoreCourse #StructuralProgression"

News from the ASAS annual meeting held in Barcelona: Denis Poddubnyy and Wilson Bautista-Molano were elected as incoming ASAS Executive Committee members

A big thank you to Mikhail Protopopov and Alexandre Sepriano for their exceptional leadership during their two-year term with Young ASAS! 🙌✨ #asas2025 #asa30yrs

📣 NEWS FROM ASAS We welcome incoming Young ASAS Leaders, Clementina Lopez Medina and Murat Torgutalp. #asas2025 #asa30yrs

📣 The Core Course on Spondyloarthritis has been granted 8 European CME credits. 👉 asas-group.org/the-2025-asas-… #SpA #Rheumatology #ASASCoreCourse